Apixaban

An anticoagulant classified as direct factor Xa inhibitor.

Apixaban is indicated for the following:

• To lower the risk of stroke and embolism in patients with nonvalvular atrial fibrillation.
• Deep vein thrombosis (DVT) prophylaxis. DVTs may lead to pulmonary embolism (PE) in knee or hip replacement surgery patients.
• Treatment of both DVT and PE.
• To reduce the risk of recurring DVT and PE after initial therapy.